title: In Vitro Effects of the Endocrine Disruptor p,p'-DDT on Human Follitropin Receptor.
abstract: 1-chloro-4-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene (p,p'-DDT) is a persistent environmental endocrine disruptor (ED). Several studies have shown an association between p,p'-DDT exposure and reproductive abnormalities.
  
  
  
  To investigate the putative effects of p,p'-DDT on the human follitropin receptor (FSHR) function.
  
  
  
  We used Chinese hamster ovary (CHO) cells stably expressing human FSHR to investigate the impact of p,p'-DDT on FSHR activity and its interaction with the receptor. At a concentration of 5 μM p,p'-DDT increased the maximum response of the FSHR to follitropin by 32 ± 7.45%. However, 5 μM p,p'-DDT decreased the basal activity and did not influence the maximal response of the closely related LH/hCG receptor to human chorionic gonadotropin (hCG). The potentiating effect of p,p'-DDT was specific for the FSHR. Moreover, in cells that did not express FSHR, p,p'-DDT had no effect on cAMP response. Thus, the potentiating effect of p,p'-DDT was dependent on the FSHR. In addition, p,p'-DDT increased the sensitivity of FSHR to hCG and to a low molecular weight agonist of the FSHR, 3-((5methyl)-2-(4-benzyloxy-phenyl)-5-{[2-[3-ethoxy-4-methoxy-phenyl)-ethylcarbamoyl]-methyl}-4-oxo-thiazolidin-3-yl)-benzamide (16a). Basal activity in response to p,p'-DDT and potentiation of the FSHR response to FSH by p,p'-DDT varied among FSHR mutants with altered transmembrane domains (TMDs), consistent with an effect of p,p'-DDT via TMD binding. This finding was corroborated by the results of simultaneously docking p,p'-DDT and 16a into the FSHR transmembrane bundle.
  
  
  
  p,p'-DDT acted as a positive allosteric modulator of the FSHR in our experimental model. These findings suggest that G protein-coupled receptors are additional targets of endocrine disruptors.
  
  
  
  Munier M, Grouleff J, Gourdin L, Fauchard M, Chantreau V, Henrion D, Coutant R, Schiøtt B, Chabbert M, Rodien P. 2016. In vitro effects of the endocrine disruptor p,p'-DDT on human follitropin receptor. Environ Health Perspect 124:991-999; http://dx.doi.org/10.1289/ehp.1510006.
authors.affiliation: MITOVASC Institute, Angers, France.
authors.forename: Mathilde
authors.initials: M
authors.lastname: Munier
authors.forename: Julie
authors.initials: J
authors.lastname: Grouleff
authors.forename: Louis
authors.initials: L
authors.lastname: Gourdin
authors.forename: Mathilde
authors.initials: M
authors.lastname: Fauchard
authors.forename: Vanessa
authors.initials: V
authors.lastname: Chantreau
authors.forename: Daniel
authors.initials: D
authors.lastname: Henrion
authors.forename: Régis
authors.initials: R
authors.lastname: Coutant
authors.forename: Birgit
authors.initials: B
authors.lastname: Schiøtt
authors.forename: Marie
authors.initials: M
authors.lastname: Chabbert
authors.forename: Patrice
authors.initials: P
authors.lastname: Rodien
mesh_terms: D000818:Animals; D016466:CHO Cells; D003412:Cricetulus; D003634:DDT / Q000633:toxicity*; D052244:Endocrine Disruptors / Q000633:toxicity*; D005640:Follicle Stimulating Hormone / Q000378:metabolism*; D006801:Humans; D018675:Toxicity Tests
chemical_list: D052244:Endocrine Disruptors; D005640:Follicle Stimulating Hormone; D003634:DDT